Urinary tract obstruction

Seminars in Nephrology

Volumn 21, Issue 2, 2001, Pages 133-145

  Klahr, Saulo ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOTENSIN; ARGININE; BETA 2 MICROGLOBULIN; CD14 ANTIGEN; CLUSTERIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MESSENGER RNA; OSTEOGENIC PROTEIN 1; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; RENIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VIMENTIN;

CELL INFILTRATION; EXTRACELLULAR MATRIX; FIBROGENESIS; HUMAN; KIDNEY FIBROSIS; KIDNEY METABOLISM; MACROPHAGE; NONHUMAN; OBSTRUCTIVE UROPATHY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; URETER OBSTRUCTION; URINARY TRACT OBSTRUCTION;

EID: 0035076282     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2001.20942     Document Type: Review

References (84)

1. Introduction: Obstructive uropathy
2. Effects of urinary tract obstruction on glomerular filtration rate and renal blood flow
3. Effect of urinary tract obstruction on renal tubular function
4. Renal metabolism in obstructive nephropathy
5. Alterations in intrarenal hormones in urinary tract obstruction
6. Inhibition of renal vasoconstriction by elevated ureteral pressure
7. The role of intrarenal angiotensin II in the hemodynamic response to unilateral obstructive uropathy
8. Clinical aspects of urinary tract obstruction
9. Diagnostic imaging approach to the patient with obstructive uropathy
10. Pathophysiology of obstructive uropathy
11. Nephrology forum: Obstructive nephropathy
12. Differential effects of ACE and AT-1 receptor inhibition on chemoattractant and adhesion molecule synthesis
13. The effect of AT2 receptor blockade on the pathogenesis of renal fibrosis
14. Angiotensin II and gene expression
15. Transforming growth factor β
16. Latent transforming growth factor-β: Structural features and mechanisms of activation
17. Biology of TGF-β in knockout and transgenic mouse models
18. Regulation of thrombospondin-I production by angiotensin II in rat heart endothelial cells
19. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells
20. Thrombospondin 1 precedes and predicts the development of tubulo-interstitial fibrosis in glomerular disease in the rat
21. Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta
22. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension
23. Hepatic expression of mature transforming growth factor beta-1 in transgenic mice results in multiple tissue lesions
24. Increased fibronectin incorporation into extracellular matrix in response to platelet-derived growth factor is mediated by transforming growth factor beta
25. PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products
26. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex
27. Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor
28. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells
29. Mechanisms of tubulointerstitial fibrosis
30. Role of tumor necrosis factor-α in the pathogenesis of glomerular diseases
31. Tumor necrosis factor alpha and mesangial cells
32. Involvement of tumor necrosis factor-α in the pathogenesis of experimental and human glomerulonephritis
33. MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells
34. The expression of mRNA for tumor necrosis factor α increases in the obstructed kidney of rats soon after unilateral ureteral ligation
35. TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells
36. Requirements for L-selectin in neutrophil-mediated lung injury in rats
37. The role of TNFRI and TNFR2 receptors in the interstitial fibrosis of obstructive nephropathy
38. Induction of CDI4 in tubular epithelial cells during kidney disease
39. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
40. Antioxidant expression in experimental hydronephrosis: Role of mechanical stretch and growth factors
41. Oxidative damage and fibrogenesis
42. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction
43. Unilateral ureteral obstruction impairs renal antioxidant enzyme activation during sodium depletion
44. Hallmark and consequences of apoptosis and necrosis in the kidney
45. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis
46. Renal tubular apoptosis after partial ureteral obstruction
47. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia
48. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
49. Induction of apoptosis in fibroblasts by c-myc protein
50. Apoptosis and the kidney
51. Cell apoptosis and proliferation in experimental chronic obstructive uropathy
52. Proximal tubular atrophy: Qualitative and quantitative structural changes in chronic obstructive nephropathy in the pig
53. Quantitative ultrastructure of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis)
54. Function and activation of NF-κB in the immune system
55. Nuclear factor-kappa: A pivotal transcription factor in chronic inflammatory diseases
56. Tissue factor expression in an animal model of hydronephrosis
57. Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction
58. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-κB
59. The nature and significance of osteopontin
60. Tubulointerstitial disease in glomerulonephritis; potential role of osteopontin (uropontin)
61. Identification and characterization of a fibroblast marker: FSP1
62. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator
63. Arrested development of the neonatal kidney following chronic ureteral obstruction
64. Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor
65. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1
66. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction
67. Increased expression of TGF-beta1 but not of its receptors contributes to human obstructive nephropathy
68. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy
69. A molecular and genetic view of human renal and urinary tract malformations
70. 2-microglobulin predicts postnatal renal function in bilateral uropathies
71. Comparative study of ACE inhibitors and AII receptor antagonists in interstitial scarring
72. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats
73. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction: Rapid communication
74. Administration of L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis
75. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy
76. Osteogenic protein-1 (Op-1) prevents renal fibrogenesis associated with ureteral obstruction
77. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning
78. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters
79. Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats
80. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney
81. Introduction of transforming growth factor-β1 antisense oligodeoxynucleotides into renal interstitial fibroblasts blocks interstitial fibrosis in unilateral ureteral obstruction
82. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study
83. Obstructive nephropathy: Lessons from cystic kidney disease
84. Time course of cytokine mRNA expression in kidneys of rats with unilateral ureteral obstruction